Clinical implications of BRAF mutation in thyroid carcinomaPUXEDDU, Efisio; DURANTE, Cosimo; AVENIA, Nicola et al.Trends in endocrinology and metabolism. 2008, Vol 19, Num 4, pp 138-145, issn 1043-2760, 8 p.Article

Expression of MMP-1 in invasive well-differentiated thyroid carcinomaMIZRACHI, Aviram; KOREN, Rumelia; HADAR, Tuvia et al.European archives of oto-rhino-laryngology. 2011, Vol 268, Num 1, pp 131-135, issn 0937-4477, 5 p.Article

Should All Papillary Thyroid Microcarcinomas Be Aggressively Treated?: An Analysis of 18,445 CasesYU, Xiao-Min; YIN WAN; SIPPEL, Rebecca S et al.Annals of surgery. 2011, Vol 254, Num 4, pp 653-658, issn 0003-4932, 6 p.Conference Paper

The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in ChernobylTAKAHASHI, Meiko; SAENKO, Vladimir A; DANILOVA, Larisa I et al.Human molecular genetics (Print). 2010, Vol 19, Num 12, pp 2516-2523, issn 0964-6906, 8 p.Article

Metastatic insular thyroid carcinoma in the pediatric patientDONNELLAN, Kimberly A; CARRON, Jeffery D; BIGLER, Steven A et al.American journal of otolaryngology (Print). 2009, Vol 30, Num 1, pp 61-64, issn 0196-0709, 4 p.Article

Recommandations pour la prise en charge des cancers thyroïdiens différenciés de souche vésiculaire = Recommendations for the management of differentiated thyroid carcinoma of vesicular originAnnales d'endocrinologie. 2007, Vol 68, issn 0003-4266, 42 p., SUP2Serial Issue

Métastase des tissus mous révélatrice d' un carcinome thyroïdien différencié = Soft tissue metastasis revealing a differentiated thyroid carcinomaKOULALI IDRISSI, K; GALUIA, F; ADERDOUR, L et al.Journal de chirurgie viscérale (Print). 2011, Vol 148, Num 2, pp 176-179, issn 1878-786X, 4 p.Article

Thyroid papillary microcarcinoma : a descriptive and meta-analysis studyROTI, Elio; DEGLI UBERTI, Ettore C; BONDANELLI, Marta et al.European journal of endocrinology. 2008, Vol 159, Num 6, pp 659-673, issn 0804-4643, 15 p.Article

The BRAF^V600E mutation in papillary thyroid microcarcinoma: does the mutation have an impact on clinical outcome?WALCZYK, Agnieszka; KOWALSKA, Aldona; KOWALIK, Artur et al.Clinical endocrinology (Oxford. Print). 2014, Vol 80, Num 6, pp 899-904, issn 0300-0664, 6 p.Article

Postoperative surveillance of thyroid carcinomaMCIVER, Bryan.Oral oncology (1997). 2013, Vol 49, Num 7, pp 684-688, issn 1368-8375, 5 p.Article

CDH16/Ksp-Cadherin Is Expressed in the Developing Thyroid Gland and Is Strongly Down-Regulated in Thyroid CarcinomasCALI, Gaetano; GENTILE, Flaviana; MOGAVERO, Sara et al.Endocrinology (Philadelphia). 2012, Vol 153, Num 1, pp 522-534, issn 0013-7227, 13 p.Article

Reduced Cx43 Gap Junction Plaque Expression Differentiates Thyroid Carcinomas From Benign DiseaseASHLIE DARR, E; PATEL, Anand D; GUOPEI YU et al.Archives of otolaryngology, head & neck surgery. 2011, Vol 137, Num 11, pp 1161-1165, issn 0886-4470, 5 p.Article

Pattern of regional metastases and prognostic factors in differentiated thyroid carcinomaSPRIANO, G; RUSCITO, P; PELLINI, R et al.Acta otorhinolaryngologica italica (Testo stampato). 2009, Vol 29, Num 6, pp 312-316, issn 0392-100X, 5 p.Article

Papillary thyroid microcarcinoma : A study of 900 cases observed in a 60-year period. DiscussionHAY, Ian D; HUTCHINSON, Maeve E; HODIN, Richard A et al.Surgery. 2008, Vol 144, Num 6, pp 980-988, issn 0039-6060, 9 p.Article

The ACR appropriateness criteria^® for thyroid carcinoma: Searching for consensus in a rapidly evolving areaYOM, Sue S; COHEN, Ezra.Oral oncology (1997). 2014, Vol 50, Num 6, pp 575-576, issn 1368-8375, 2 p.Article

What Is the Best Treatment for Papillary Thyroid Microcarcinoma?WU, Arthur W; NGUYEN, Chau; WANG, Marilene B et al.The Laryngoscope. 2011, Vol 121, Num 9, pp 1828-1829, issn 0023-852X, 2 p.Article

Thyroid Carcinoma — Experience at Jinnah Postgraduate Medical Centre KarachiBUKHARI, Uzma; SADIQ, Saleem; JAWAID HUSSIN MEMON et al.Journal of the Pakistan Medical Association. 2010, Vol 60, Num 5, pp 365-367, issn 0030-9982, 3 p.Article

Surgical Practice Patterns in the Treatment of Papillary Thyroid MicrocarcinomaWU, Arthur W; WANG, Marilene B; NGUYEN, Chau T et al.Archives of otolaryngology, head & neck surgery. 2010, Vol 136, Num 12, pp 1182-1190, issn 0886-4470, 9 p.Article

Guidelines for the management of differentiated thyroid carcinomas of vesicular originBORSON-CHAZOT, F; BARDET, S; WEMEAU, J.-L et al.Annales d'endocrinologie. 2008, Vol 69, Num 6, pp 472-486, issn 0003-4266, 15 p.Article

Medullary thyroid microcarcinoma recommendations for treatment : A single-center experienceSCHEUBA, Christian; KASERER, Klaus; BIEGLMAYER, Christian et al.Surgery. 2007, Vol 142, Num 6, pp 1003-1010, issn 0039-6060, 8 p.Article

Metastasis from Thyroid CarcinomaKATTEPUR, Abhay K; GOPINATH, Kodaganur S.The New England journal of medicine. 2014, Vol 370, Num 22, issn 0028-4793, p. 2131Article

From nodule to differentiated thyroid carcinoma: Contributions of molecular analysis in 2012ALBAREL, Frédérique; CONTE-DEVOLX, Bernard; OLIVER, Charles et al.Annales d'endocrinologie. 2012, Vol 73, Num 3, pp 155-164, issn 0003-4266, 10 p.Article

Clinical significance of residual occult malignancy in thyroid carcinomaTURANLI, Sevim; ASLAN, Sabahattin; CETIN, Abdullah et al.American journal of otolaryngology (Print). 2011, Vol 32, Num 5, pp 398-401, issn 0196-0709, 4 p.Article

Immunohistochemical detection, regulation and antiproliferative function of G-protein-coupled receptor kinase 2 in thyroid carcinomasMETAYE, Thierry; LEVILLAIN, Pierre; KRAIMPS, Jean-Louis et al.Journal of endocrinology. 2008, Vol 198, Num 1, pp 101-110, issn 0022-0795, 10 p.Article

Completeness and validity in a national clinical thyroid cancer database: DATHYRCALONDERO, Stefano Christian; MATHIESEN, Jes Sloth; GODBALLE, Christian et al.Cancer epidemiology (Print). 2014, Vol 38, Num 5, pp 633-637, issn 1877-7821, 5 p.Article